Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. - Wikidata - wikimedia - TriplyDB

Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.

Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.

http://www.wikidata.org/entity/Q45710554

about

Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults The incidence of herpes zoster in a United States administrative database Microbiology laboratory and the management of mother-child varicella-zoster virus infection Predictors of shingles reports at diagnosis of common variable immunodeficiency and selective immunoglobulin G subclass deficiency in 212 Alabama adults Evaluation of efficacy and effectiveness of live attenuated zoster vaccine Reducing the burden of Herpes Zoster in Italy Vaccination against Herpes Zoster and Postherpetic Neuralgia No increased risk of herpes zoster found in cirrhotic patients: a nationwide population-based study in Taiwan.Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain)Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study.Preventing varicella-zoster disease IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies.Management and prevention of herpes zoster: A Canadian perspective.Herpes zoster vaccine for the elderly: boosting immunity.Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.Disseminated cutaneous herpes zoster in an immunocompetent elderly patient Vaccines: past, present and future.Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve.Pathogenesis of varicelloviruses in primates Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis.Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.A nationwide population-based cohort study to identify the correlation between heart failure and the subsequent risk of herpes zoster.Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.Immunogenicity and safety of ZOSTAVAX(®) approaching expiry potency in individuals aged ≥50 years.The Characterization of Varicella Zoster Virus-Specific T Cells in Skin and Blood during Aging.Interferon Gamma Prolongs Survival of Varicella-Zoster Virus-Infected Human Neurons In Vitro Mechanisms of immunosenescence: lessons from models of accelerated immune aging.Varicella-zoster vaccine in the USA: success for control of disease severity, but what next?Definition and management of varicella zoster virus-associated meningoradiculitis: a case report Defective T Memory Cell Differentiation after Varicella Zoster Vaccination in Older Individuals.Varicella-zoster virus-specific enzyme-linked immunospot assay responses and zoster-associated pain in herpes zoster subjects Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study.Prevention of shingles by varicella zoster virus vaccination.Zoster vaccine live.Asthma as a risk factor for zoster in adults: A population-based case-control study.

P2860

Q24193819-A8C82A6E-9E16-42B7-BDE0-A28345D59107 Q24242809-8E26E343-F862-4297-9800-FE6B590FEE37 Q24549730-44A70C26-6041-406B-A0AA-BC136EA8A91B Q26738745-E28F8DE0-F932-4E51-B93A-258B95E19575 Q26852530-7239307F-D649-4FC5-8921-BA96FC93CE7F Q26866473-F6C1150F-2D1E-4363-91D5-28028431B769 Q26998625-43977108-83A2-4AE3-A9F8-307E8FD99C3C Q28276808-08404050-272B-4CD1-9FE2-1C2C7670A805 Q31156767-926C3E97-F6DC-46DC-85D1-D17712175E4C Q33578057-78AEAC4A-DA42-4200-B280-10966CF9342E Q33585318-1C28BB39-0A81-4FEA-8EA2-99C874BFCE16 Q33585349-42152E25-1F47-4A32-B199-A163829E5F76 Q33626007-108671DD-0834-43DE-9743-8F3F9561C5E0 Q33719386-E0E9FDD8-EFC3-4D64-B3DB-34ADDF87FAC2 Q33723698-B03336E6-D5C4-4756-A667-011470B3F363 Q33779986-7124F070-1A95-4554-B087-CE805FD6A0AA Q33956779-7417666C-06EC-448B-9D30-CFBCE29C33F7 Q34007433-DC6D1253-C958-4523-ABAE-99D47474D72B Q34064838-123AC1CF-840B-4532-8934-7E10DBADFAEC Q34259163-3434742C-9F69-48C5-8147-0BC181439F2E Q34409178-37E133E9-A2F0-4739-BAB0-16A8256E8549 Q34430200-760D56EC-ACFC-4DF1-BF84-1F008F74AB7B Q34714480-8D43A9A1-C062-4569-8B27-FD1D6D50FF95 Q34785366-BEED8533-A45B-4066-8D97-B53901F2C32A Q34851473-BCA67BFF-99B3-4250-BBC5-56B624E6B404 Q34991446-461457CD-A6AB-40E4-88D1-6FB20216D549 Q35016212-9115AE2D-7799-4ED3-970D-F02AA2D86061 Q35088160-304F6452-97C4-4C14-8E08-BEB9B65E515F Q35667362-89285383-D8B7-4627-8099-8712EED05038 Q35752877-9A9A4747-F3AA-494F-81A5-E209E32321CF Q35758621-F5443F70-B7C8-4A3B-9649-D99160C8ABB0 Q35880403-55A96956-7100-4FCB-B8D9-3202DEFB431C Q36066227-8F9B188F-A6BE-4715-B985-B2F66DA5C051 Q36145354-A13077CE-2D8B-480B-98DC-453A8F41FD46 Q36169646-CA794254-51D0-4735-86AD-9FB0C6057614 Q36191676-739CFE16-5123-4F2A-ADD3-FCC185B0EC12 Q36225734-562E45C1-E8CD-4D30-8B26-D93286E97070 Q36600317-0BEFA65C-A768-4920-85AD-DF9555D03A32 Q36861648-59511862-0FFB-4020-80CF-52EC89A95061 Q36880196-13C5E749-0D24-4BFE-A5C8-A48B46F371F1

P2860

Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.

http://www.wikidata.org/entity/Q45710554

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Decline in varicella-zoster vi ...... with a high-dose VZV vaccine.

@en

Decline in varicella-zoster virus

@nl

type

label

Decline in varicella-zoster vi ...... with a high-dose VZV vaccine.

@en

Decline in varicella-zoster virus

@nl

prefLabel

Decline in varicella-zoster vi ...... with a high-dose VZV vaccine.

@en

Decline in varicella-zoster virus

@nl

P1433

Q45710554-DDAAB6CF-2697-4877-9D96-DE34F91337D1

P1476

Q45710554-2CA7DD0A-06A9-492E-8141-ACBF23B596A2

P2093

Q45710554-15160D6F-F17B-4DC0-BA33-C6F08E0B86C4

Q45710554-4CA05AE7-B97C-4F03-B7B2-151DDADA4BEF

Q45710554-673B0C68-65BA-4AA7-B3DB-FA957ADEF0EA

Q45710554-72F193F6-B1C8-4B8E-8C21-05217BEFC92E

Q45710554-7D07EBCC-D02D-494F-A2BF-1C0F7D2B626F

Q45710554-901A2C6E-CAFD-458C-A5C8-AE0807BCC20C

Q45710554-9664E56F-97BB-4284-81A4-0D633710CD21

Q45710554-A085F724-A0AA-4B77-B384-38FCF1757112

Q45710554-A43C9071-35C3-41C3-AE19-25586BB091F7

Q45710554-C1776559-FDF7-4A11-B10A-0B1450B7E510

P304

Q45710554-BD226FAC-22CB-4738-88EE-6D0B44B4143D

P31

Q45710554-B91B8F13-E04B-40ED-9D0F-0695AA07BD68

P356

Q45710554-5261F96A-92BD-4C9A-8F2F-D4B80AD4F4B2

P407

Q45710554-A65844CF-369D-493B-B0F9-881AFBE6BA9C

P433

Q45710554-FBBB03DE-E00B-4D45-A6F5-BFBAF8F85423

P478

Q45710554-840622C7-E537-4AAE-95B3-F0057CFA6550

P577

Q45710554-BB689834-A5BD-4312-8A91-DF6933A117FE

P5875

Q45710554-A44F25CA-B186-434B-A3FA-6406A04E66DB

P698

Q45710554-EB3F9AFA-DE2D-4984-BA8F-71017ECDC1BE

P356

P1433

The Journal of Infectious Diseases

P1476

Decline in varicella-zoster vi ...... with a high-dose VZV vaccine.

@en

P2093

Alan Shaw

http://www.w3.org/2001/XMLSchema#string

Anthony R Hayward

http://www.w3.org/2001/XMLSchema#string

Christina Y Chan

http://www.w3.org/2001/XMLSchema#string

David J J Li

http://www.w3.org/2001/XMLSchema#string

Debra Barber

http://www.w3.org/2001/XMLSchema#string

Ira Chalikonda

http://www.w3.org/2001/XMLSchema#string

Ivan S F Chan

http://www.w3.org/2001/XMLSchema#string

Jeffrey G Smith

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Silber

http://www.w3.org/2001/XMLSchema#string

Katia Schlienger

http://www.w3.org/2001/XMLSchema#string

P304

1336-1344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/379048

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

188

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9029391

http://www.w3.org/2001/XMLSchema#string

P698

14593591

http://www.w3.org/2001/XMLSchema#string